N-glycosylation Dictates Proper Processing of Organic Anion Transporting Polypeptide 1B1

被引:36
|
作者
Yao, Juan [1 ]
Hong, Weifang [1 ]
Huang, Jiujiu [1 ]
Zhan, Kai [1 ]
Huang, Hong [2 ]
Hong, Mei [1 ]
机构
[1] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China
[2] Univ S Florida, Sch Informat, Tampa, FL USA
来源
PLOS ONE | 2012年 / 7卷 / 12期
基金
中国国家自然科学基金;
关键词
OATP TRANSPORTERS; DRUG; MEMBRANE; POLYMORPHISMS; DISPOSITION; KIDNEY; IMPACT; CELLS;
D O I
10.1371/journal.pone.0052563
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Organic anion transporting polypeptides (OATPs) have been extensively recognized as key determinants of absorption, distribution, metabolism and excretion (ADME) of various drugs, xenobiotics and toxins. Putative N-glycosylation sites located in the extracellular loops 2 and 5 is considered a common feature of all OATPs and some members have been demonstrated to be glycosylated proteins. However, experimental evidence is still lacking on how such a post-translational modification affect the transport activity of OATPs and which of the putative glycosylation sites are utilized in these transporter proteins. In the present study, we substituted asparagine residues that are possibly involved in N-glycosylation with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of OATP1B1, an OATP member that is mainly expressed in the human liver. Our results showed that Asn134 and Asn516 are used for glycosylation under normal conditions; however, when Asn134 was mutagenized, an additional asparagine at position 503 is involved in the glycosylation process. Simultaneously replacement of all three asparagines with glutamines led to significantly reduced protein level as well as loss of transport activity. Further studies revealed that glycosylation affected stability of the transporter protein and the unglycosylated mutant was retained within endoplasmic reticulum.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Importance of N-Glycosylation for the Expression and Function of Human Organic Anion Transporting Polypeptide 2B1
    Li, Ying
    Liu, Han
    Liang, Ting
    Han, Wanjun
    Bo, Zheyue
    Qiu, Tian
    Li, Jiawei
    Xu, Mingming
    Wang, Weipeng
    Yang, Shuang
    Gui, Chunshan
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (10) : 1347 - 1356
  • [2] Interaction of porphyrins with human organic anion transporting polypeptide 1B1
    Campbell, Scott D.
    Lau, Wan F.
    Xu, Jinghai J.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 182 (01) : 45 - 51
  • [3] Oligomerization Study of Human Organic Anion Transporting Polypeptide 1B1
    Ni, Chunxu
    Yu, Xuan
    Fang, Zihui
    Huang, Jiujiu
    Hong, Mei
    MOLECULAR PHARMACEUTICS, 2017, 14 (02) : 359 - 367
  • [4] EFFECT OF RARE GENETIC VARIANTS ON ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1
    Kiander, W.
    Kidron, H.
    Niemi, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 3 - 3
  • [5] MIDAZOLAM IS NOT A SUBSTRATE OF HEPATIC ORGANIC ANION-TRANSPORTING POLYPEPTIDE 1B1
    Ziesenitz, V.
    Koenig, S.
    Weiss, J.
    Burhenne, J.
    Mikus, G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 19 - 19
  • [6] Schisandrin A and B induce organic anion transporting polypeptide 1B1 transporter activity
    Guo, Cheng-Xian
    Deng, Sheng
    Yin, Ji-Ye
    Liu, Zhao-Qian
    Zhang, Wei
    Zhou, Hong-Hao
    PHARMAZIE, 2015, 70 (01): : 29 - 32
  • [7] Amino-terminal region of human organic anion transporting polypeptide 1B1 dictates transporter stability and substrate interaction
    Wang, Xuyang
    Chen, Jie
    Xu, Shaopeng
    Ni, Chunxu
    Fang, Zihui
    Hong, Mei
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 378
  • [8] Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1
    Gui, Chunshan
    Hagenbuch, Bruno
    PROTEIN SCIENCE, 2009, 18 (11) : 2298 - 2306
  • [9] Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
    Niemi, M
    Backman, JT
    Kajosaari, LI
    Leathart, JB
    Neuvonen, M
    Daly, AK
    Eichelbaum, M
    Kivistö, KT
    Neuvonen, PJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) : 468 - 478
  • [10] ABSOLUTE EXPRESSION LEVEL OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1 IN HUMAN LIVER
    Terasaki, Tetsuya
    Hakata, Yuka
    Tachikawa, Masanori
    Uchida, Yasuo
    Ohtsuki, Sumio
    DRUG METABOLISM REVIEWS, 2015, 47 : 271 - 271